PALO ALTO, Calif. and DURHAM, N.C., June 04, 2021 /PRNewswire/ -- Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women.
Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases
Previous
Previous
POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI
Next
Next